Home › Funds › TRIGLAV INVESTMENTS, D.O.O. › LLY

TRIGLAV INVESTMENTS, D.O.O. position in LLY

Eli Lilly & Co · Health Care

TRIGLAV INVESTMENTS, D.O.O. reported holding 57,687 shares of LLY (Eli Lilly & Co) in its Q3 2026 13F filing — a position valued at US$66.8M, representing 3.52% of its reported portfolio and ranking #7 among its reported holdings. TRIGLAV INVESTMENTS, D.O.O. has disclosed LLY holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)57.69K sh
Reported value held$66.76M
Portfolio Weight3.52%
First reportedQ4 2024
Last changeAdd
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How TRIGLAV INVESTMENTS, D.O.O.'s LLY position evolved

TRIGLAV INVESTMENTS, D.O.O. first disclosed a stake in LLY in Q4 2024 at 55,548 shares (US$42.9M). The position peaked in Q3 2026 at 57,687 shares, worth US$66.8M. Across 8 filings, TRIGLAV INVESTMENTS, D.O.O. increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 57,687 shares valued at US$66.8M — an increase of 4,654 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 55.55K $42.88M New
Q1 2025 53.24K $43.97M Reduce
Q2 2025 54.04K $42.12M Add
Q3 2025 51.57K $39.34M Reduce
Q4 2025 47.65K $51.20M Reduce
Q1 2026 49.21K $45.27M Add
Q2 2026 53.03K $63.61M Add
Q3 2026 57.69K $66.76M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (Eli Lilly & Co) is a Health Care company. 38 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →

FAQ

How long has TRIGLAV INVESTMENTS, D.O.O. held LLY?

TRIGLAV INVESTMENTS, D.O.O. has disclosed LLY holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is TRIGLAV INVESTMENTS, D.O.O.'s current position in LLY?

As of Q3 2026, TRIGLAV INVESTMENTS, D.O.O. holds 57.69K shares of LLY (Eli Lilly & Co), valued at $66.76M, representing 3.52% of its reported portfolio and ranking #7.

Has TRIGLAV INVESTMENTS, D.O.O. been buying or selling LLY?

In the latest 13F filing (Q3 2026), TRIGLAV INVESTMENTS, D.O.O. increased its position in LLY. The position peaked in Q3 2026 at 57.69K shares.

Which other funds hold LLY?

Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, BlackRock Inc, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.